Qure.ai vs Aidoc

A side-by-side look at scores, pricing and features — with RECATOOLS' ASEAN-aware verdict for each.

Qure.ai FDA-cleared AI radiology platform detecting TB, stroke, lung cancer an... Visit Aidoc Always-on clinical AI that triages CT findings — ICH, PE, spinal fract... Visit
RECATOOLS Score 8.2 / 10 8.2 / 10
Capability 9 9.2
Value for money 7.5 6.5
Ease of use 7 7.5
ASEAN readiness 8.5 5.5
API quality 7 7
Pricing Enterprise Enterprise
Free tier No free tier; enterprise contracts only; trial demos available via sales No free tier; demo available on request
Paid from Custom enterprise pricing; contact sales for per-scan or site-licence quotes Custom enterprise pricing; contact sales for per-site or per-volume quotes
Has API
Open source
Free to use
Users 34M+ lives impacted across 4,800+ clinical sites in 105+ countries (as of late 2025) nearly 2,000 hospitals worldwide; 150+ US health systems; 60M+ cases/year
Founded 2016 2016
Maker Independent (Series D — Lightspeed, 360 ONE Asset, Merck GHI Fund) Aidoc Medical Ltd.
Verdict

Qure.ai is one of the most credentialled and widely deployed AI radiology platforms in the world, with a regulatory portfolio (26 FDA-cleared indications, Class IIb CE under EU MDR, CDSCO Class B in India, registrations...

Aidoc leads the FDA-cleared radiology AI market by clearance count and clinical breadth. Its CARE foundation model — the first to receive FDA clearance for 14 simultaneous abdominal CT indications — represents a genuine...

Full review → Full review →
← Back to AI Directory

Comparisons cover up to 4 tools. Scores are RECATOOLS editorial assessments; verify current pricing on each vendor's site.